Skip to main content
mSphere logoLink to mSphere
. 2024 Feb 15;9(3):e00030-24. doi: 10.1128/msphere.00030-24

Sexual transmission of urogenital bacteria: whole metagenome sequencing evidence from a sexual network study

Kayla A Carter 1,2,, Michael T France 1,2, Lindsay Rutt 1, Lisa Bilski 3,3, Sebastian Martinez-Greiwe 3,4, Mary Regan 3, Rebecca M Brotman 1,4, Jacques Ravel 1,2,
Editor: Maria L Marco5
PMCID: PMC10964427  PMID: 38358269

ABSTRACT

Sexual transmission of the urogenital microbiota may contribute to adverse sexual and reproductive health outcomes. The extent of sexual transmission of the urogenital microbiota is unclear as prior studies largely investigated specific pathogens. We used epidemiologic data and whole metagenome sequencing to characterize urogenital microbiota strain concordance between participants of a sexual network study. Individuals who screened positive for genital Chlamydia trachomatis were enrolled and referred their sexual contacts from the prior 60–180 days. Snowball recruitment of sexual contacts continued for up to four waves. Vaginal swabs and penile urethral swabs were collected for whole metagenome sequencing. We evaluated bacterial strain concordance using inStrain and network analysis. We defined concordance as ≥99.99% average nucleotide identity over ≥50% shared coverage; we defined putative sexual transmission as concordance between sexual contacts with <5 single-nucleotide polymorphisms per megabase. Of 138 participants, 74 (54%) were female; 120 (87%) had genital chlamydia; and 43 (31%) were recruited contacts. We identified 115 strain-concordance events among 54 participants representing 25 bacterial species. Seven events (6%) were between sexual contacts including putative heterosexual transmission of Fannyhessea vaginae, Gardnerella leopoldii, Prevotella amnii, Sneathia sanguinegens, and Sneathia vaginalis (one strain each), and putative sexual transmission of Lactobacillus iners between female contacts. Most concordance events (108, 94%) were between non-contacts, including eight female participants connected through 18 Lactobacillus crispatus and 3 Lactobacillus jensenii concordant strains, and 14 female and 2 male participants densely interconnected through 52 Gardnerella swidsinskii concordance events.

IMPORTANCE

Epidemiologic evidence consistently indicates bacterial vaginosis (BV) is sexually associated and may be sexually transmitted, though sexual transmission remains subject to debate. This study is not capable of demonstrating BV sexual transmission; however, we do provide strain-level metagenomic evidence that strongly supports heterosexual transmission of BV-associated species. These findings strengthen the evidence base that supports ongoing investigations of concurrent male partner treatment for reducing BV recurrence. Our data suggest that measuring the impact of male partner treatment on F. vaginae, G. leopoldii, P. amnii, S. sanguinegens, and S. vaginalis may provide insight into why a regimen does or does not perform well. We also observed a high degree of strain concordance between non-sexual-contact female participants. We posit that this may reflect limited dispersal capacity of vaginal bacteria coupled with individuals’ comembership in regional transmission networks where transmission may occur between parent and child at birth, cohabiting individuals, or sexual contacts.

KEYWORDS: urogenital microbiome, vaginal microbiome, penile microbiome, bacterial vaginosis, metagenomics, strain concordance

INTRODUCTION

The urogenital microbiome is a primary line of defense against sexually transmitted infections (STI), including HIV (1). The vaginal microbiome of reproductive-age cisgender women is often dominated by a single Lactobacillus species (2). Dominance of D-lactic acid (LA) producing lactobacilli, including Lactobacillus crispatus, Lactobacillus gasseri, and Lactobacillus jensenii, is considered optimal due to strong and consistent associations with positive sexual and reproductive health outcomes (3, 4) and D-LA’s beneficial effects on host epithelium (5, 6). Lactobacillus iners, which is believed to be the most prevalent and abundant vaginal bacterial species worldwide (2, 79), produces only L-LA (6, 10). Compared to D-LA-producing lactobacilli, L. iners dominance appears to provide less protection against STI and is approximately twice as likely to shift toward diverse, non-optimal communities resembling bacterial vaginosis (BV) (69, 11, 12). BV is characterized by low/no lactobacilli and abundant Gram-negative anaerobes, including Gardnerella, “Candidatus Lachnocurva vaginae” (formerly BV-associated bacterium 1 [13]), Fannyhessea (formerly Atopobium [14]), Prevotella, and Sneathia (1517). A quarter to third of women have BV; around half of cases are symptomatic with thin, gray/white, homogeneous vaginal discharge and/or fishy/amine vaginal odor (15, 17). Symptoms can severely negatively impact psychosocial well-being, self-esteem, and sexual satisfaction (18), and BV is associated with various adverse outcomes including HIV/STI acquisition, preterm birth, and cervical disease progression (1922). First-line BV treatments include metronidazole and clindamycin; however, recurrence is high with as many as 60% having a recurrent episode within 1 year (23).

The penile microbiome is less well studied than the vaginal microbiome, but evidence suggests it may play a role in modulating local inflammation and HIV risk (1, 24). This study characterized the penile urethral microbiome, so we focus on the penile urethral microbiome here, as opposed to the penile cutaneous microbiome. Single-species dominance is less common in the male urethra than the vagina (2529), and the overall abundance of penile bacteria is typically lower than of vaginal bacteria (25, 28). Corynebacterium, Finegoldia, Peptoniphilus, Staphylococcus, and Streptococcus are commonly detected in the male urethra (2529). Their abundance differs by circumcision status, with Corynebacterium, Staphylococcus, and Streptococcus being higher among circumcised individuals and Finegoldia and Peptoniphilus higher among individuals with intact foreskin (27, 29). Vaginal lactobacilli, namely, L. iners, and BV-associated bacteria, primarily Gardnerella, Prevotella, and Sneathia, are also regularly detected in the male urethra (2529). Vaginal bacteria are more prevalent and abundant in urethras of men reporting vaginal sex and men whose sex partners have BV (2527, 29), and penile urethral microbiota composition can robustly predict incident BV in sex partners (27). In the vagina and male urethra, BV-associated anaerobes are linked to increased local levels of pro-inflammatory immune mediators (1, 24, 30).

Detecting vaginal bacteria in the penile microbiome suggests they may be sexually transmitted. Likewise, epidemiologic evidence consistently indicates BV may be sexually transmitted (between heterosexual contacts and between women who have sex with women [WSW]) (3134), although this is debated (3538). Early trials of BV male partner treatment (concurrently treating male sex partners of women with BV using similar regimens) showed little benefit for reducing BV recurrence; however, these trials had serious methodologic limitations and cannot be taken as strong evidence against BV sexual transmission (3946). There is renewed interest in BV male partner treatment (28, 4749), and while ongoing work addresses major limitations of early trials, the design and evaluation of BV male partner treatment regimens are constrained by our limited understanding of sexual transmission of urogenital bacteria. Prior molecular biology studies of strain-level urogenital bacterial concordance are restricted to a prespecified genus or species, predominantly overt pathogens (5056). Prior metataxonomic studies of species-level concordance do not provide sufficient resolution to infer transmission (26, 28, 49, 57, 58). To address these limitations, we used genome-resolved metagenomics to identify concordant strains in the vaginal and penile microbiomes of individuals enrolled in the Sexually Transmitted Infection Network Groups (STING) study.

RESULTS

Participants were recruited from seven clinics providing genital Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) screening in the Baltimore, MD, USA, metropolitan area: four clinics serving the general population and three pop-up clinics serving large universities. Female and male individuals were eligible if they screened positive for genital CT by nucleic acid amplification test (NAAT), were 16–40 years old and were willing to provide names and contact information of all sexual contacts from the prior 60 or 180 days (switched from 60 to 180 partway through recruitment). These participants will be referred to as wave 1. Sexual contacts of wave 1 participants were then invited to enroll. Contacts were eligible if they were 16–40 years old, willing to undergo CT/NG screening, and willing to provide names and contact information of sexual contacts from the prior 60 or 180 days. These participants will be referred to as wave 2. Recruiting sexual contacts via this snowball approach continued for up to four waves (Fig. 1).

Fig 1.

Fig 1

Hypothetical example of STING snowball recruitment. Wave 1 participants who tested positive for genital CT referred their sexual contacts from the prior 60 or 180 days (switched from 60 to 180 partway through recruitment) for enrollment in wave 2. Snowball recruitment of sexual contacts continued for up to four waves. Individuals with genital CT infection are indicated by the cartoon bacterium on their bottom right. This is a hypothetical example; it does not depict enrollment patterns observed in STING.

All participants underwent a reproductive tract examination, during which vaginal or penile urethral swabs were collected. Swabs were used for whole metagenome sequencing, and metagenomes were successfully sequenced for 138 of 139 participants (median 48,744,779 read pairs; range: 132,491–179,383,783). Of these 138 participants, half were female, two-thirds reported Black race, and the median age was 21 (Table 1). Most participants (87%) had CT; two had NG. Ninety-three participants were enrolled in wave 1, 63 of which (46% of total) had no sexual contacts enrolled. The remaining 33 wave 1 participants (24%) had 40 sexual contacts enrolled (wave 2, 29%). Wave 2 participants had two sexual contacts enrolled (wave 3), and wave 3 participants had one sexual contact enrolled (wave 4).

TABLE 1.

Participant characteristics overall and stratified by gender

Characteristics All participants
(N = 138)
Female participants
(n = 74)
Male participants
(n = 64)
n % n % n %
Race
 Asian 5 4 4 5 1 2
 Black 92 67 49 66 43 67
 Hispanic 5 4 2 3 3 5
 Mixed 6 4 4 5 2 3
 white 30 22 15 20 15 23
Age (years)a 21 19–23 20 19–22 21 20–24
Lifetime male sexual contactsa 2.5 0–9 8 3–10 0 0–0
 Prefer not to answer 8 6 3 4 5 8
Lifetime female sexual contactsa 1 0–8.25 0 0–0.5 9 4–20
 Prefer not to answer 18 13 7 9 11 17
Current contraception useb
 Condom 38 51
 Hormonal 41 55
 Copper IUD 1 1
 Other 16 22
Waves and sexual contactsc
 Wave 1, no contacts 63 46 38 51 25 39
 Wave 1, index contact 33 24 25 34 8 13
 Wave 2, sexual contact 40 29 10 14 30 47
 Wave 3, sexual contact 2 1 1 1 1 2
 Wave 4, sexual contact 1 1 0 0 1 2
Enrollment sited
 General population clinic 31 23 19 26 12 19
 University pop-up clinic 65 47 44 59 21 33
 Sexual contactd 42 30 11 15 31 48
CSTe
 I, L. crispatus dominated 7 5 7 10 0 0
 III, L. iners dominated 14 10 13 18 1 2
 IV-A, high “Ca. Lachnocurva vaginae,” moderate Gardnerella 15 11 13 18 2 3
 IV-B, high Gardnerella 63 46 34 46 29 45
 IV-C, diverse, more even 35 25 4 5 31 48
 V, L. jensenii dominated 4 3 3 4 1 2
Self-reported urogenital symptoms 50 36 40 54 10 16
Genital CT (NAAT) 120 87 71 96 49 77
Genital NG (NAAT) 2 1 0 0 2 3
Clinician-evaluated conditionsf
 PIDg 0 0
 Abnormal vaginal discharge 11 15
 Cervical discharge 11 15
 Amsel BV 7 10
 Mucopurulent cervicitis 1 1
 Vulvovaginal candidiasis 5 7
 Penile discharge 0 0
 Urethritis 2 3
 Circumcised 53 83
  Not recorded 4 6
a

Continuous data are presented as median and interquartile range.

b

Only female participants were asked about current contraceptive use, so these data are only presented for female participants.

c

Wave and partnership counts overall and for male participants sum to 1 greater than the total because one male participant was included in waves 2 and 3. Percentages for overall and male participants are out of the total number of unique participants (i.e., 138 overall and 64 males).

d

Enrollment site was recorded only for wave 1 participants, not for sexual contacts.

e

CSTs were assigned using VALENCIA; CST, community state type.

f

PID, vaginal and cervical discharge, mucopurulent cervicitis, and vulvovaginal candidiasis were evaluated only among female participants. Penile discharge, urethritis, and circumcision status were evaluated only among male participants.

g

PID, pelvic inflammatory disease.

Genome-resolved metagenomics

We determined metagenome taxonomic composition by mapping to the VIRGO non-redundant gene catalog (59) and assigned community state types (CSTs) using VALENCIA (2). We performed de novo assembly on each metagenome, individually, using metaSPAdes (60) and divided assembled contigs into metagenome-assembled genomes (MAGs) using MaxBin2, MetaBAT2, and MetaDecoder (6163). We consolidated and refined bins using MetaWRAP and CheckM (64, 65), retaining MAGs that were ≥90% complete and <5% contaminated for analyses. We retained 507 MAGs representing 97 taxa (Table S1); their median completeness and contamination were 98.1% (interquartile range ([IQR] 95.6%–99.4%) and 0.2% (IQR 0%-0.7%), respectively. MAG taxonomy was assigned using GTDB-Tk (66).

While CST IV-B (high Gardnerella spp.) was prevalent among female and male participants (46% and 43%, respectively), most remaining female participants were assigned to CST I (L. crispatus dominated, 10%), CST III (L. iners dominated, 18%), or CST IV-A (high “Ca. L. vaginae,” 18%) (Fig. 2). Most remaining male participants were assigned to CST IV-C (moderate-to-high Corynebacterium spp., Propionimicrobium spp., 48%).

Fig 2.

Fig 2

Urogenital microbiota composition, sex, and genital CT status of STING participants. Urogenital microbiota composition from whole metagenome sequencing. CSTs assigned using VALENCIA. The plot depicts the taxa with the top 10 mean relative abundances among female and male participants (calculated separately) as well as any remaining taxa that have a putative sexual transmission event.

We used ZicoSeq to compare vaginal and penile metagenome relative abundances (67). Controlling family-wise error rate (FWER) at 1%, we found that L. iners and Parvimonas spp. were significantly enriched in vaginal metagenomes compared to penile (Fig. 3). Nineteen taxa were significantly enriched in penile metagenomes compared to vaginal: Acinetobacter spp., Actinobacillus spp., Actinobaculum spp., Actinomyces spp., Bifidobacterium spp., Brevibacterium spp., Corynebacterium spp., Escherichia coli, Finegoldia spp., Haemophilus spp., Klebsiella spp., Lactobacillus delbrueckii, Lactococcus spp., Paracoccus spp., Propionimicrobium spp., Salmonella spp., Sneathia spp., Staphylococcus spp., and Veillonella spp. We additionally compared abundances according to CT status among penile metagenomes, which showed minor differences (Fig. S1). We did not perform a similar analysis among vaginal metagenomes as all but three female participants had CT.

Fig 3.

Fig 3

Differential abundance of taxa between vaginal and penile metagenomes. R2 is the proportion of variance in metagenome composition (across vaginal and penile samples) explained by a given taxon. The vertical dashed line at R2 = 0 indicates no difference in abundance between vaginal and penile metagenomes, negative R2 values indicate enrichment in vaginal metagenomes, and positive R2 values indicate enrichment in penile metagenomes. We controlled the FWER at 1%, as indicated by the horizontal dashed line at log10(FWER − adjusted P) = 2. All taxa that are differentially abundant at this FWER fall above the horizontal line and are labeled. Taxa that are presented in other figures are also labeled, regardless of significance.

Strain-concordance summary

We used inStrain to identify concordant strains between participants (68). We used an all-vs-all strategy to build inStrain profiles for each metagenome-MAG pair by mapping sequence reads against MAGs using Bowtie2 (69). To identify strain concordance, we applied stringent filters requiring ≥99.99% sequence similarity [population average nucleotide identity (popANI)] over ≥50% shared coverage.

We identified 115 concordant strains among 54 participants representing 25 taxa (Fig. 4). For 17 taxa (68%), we observed one concordance event (Tables 2 and 3). The remaining concordant taxa were Gardnerella leopoldii (n = 8 events), Gardnerella swidsinskii (n = 52), L. crispatus (n = 18), L. iners (n = 6), L. jensenii (n = 3), Lactobacillus mulieris (formerly L. jensenii [70]) (n = 3), Prevotella spp. (n = 4), and Prevotella amnii (n = 4). Several taxa were concordant exclusively between sexual contacts (Fannyhessea vaginae, Gardnerella vaginalis A, Sneathia sanguinegens, Sneathia vaginalis ([formerly Sneathia amnii] [71]); some were concordant between contacts and non-contacts (G. leopoldii, L. iners, and P. amnii), and the remaining 18 were exclusively concordant between non-contacts. Relative abundances of concordant strains generally reflected their relative abundances in the study overall (Fig. 2; Tables 2 and 3). The distribution of population single-nucleotide polymorphisms (popSNP) per megabase (Mbp) differed across taxa (lowest median = 3 for L. jensenii, highest median = 59 for G. swidsinskii; Kruskal-Wallis P = 0.02; Fig. 5). There were fewer popSNP/Mbp when strains were concordant between sexual contacts (contacts median = 1, non-contacts median = 47; Kruskal-Wallis P = 9×10−5).

Fig 4.

Fig 4

Network diagram of strain-concordance events between sexual contacts and non-contacts. Each node (circle or diamond) represents one participant. Each edge (line between nodes) represents a strain-concordance event between connected nodes. Thin edges indicate concordance between non-contacts. Thick edges indicate concordance between sexual contacts. Putative sexual transmission is indicated by colored asterisks adjacent to and colored the same as edges representing sexual transmission. Concordant strains were required to have ≥99.99% popANI across ≥50% of shared coverage. Sexual transmission was defined as strain concordance between sexual contacts with <5 popSNP/Mbp. popANI is estimated by inStrain based on popSNPs, which are called when two samples share no alleles at a given site. F, female; M, male.

TABLE 2.

Interpersonal characteristics of strain-concordance events between sexual contacts

Dyad members Taxon N concordance events withina: Same CSTb Weeks between enrollment Relative abundances in dyad
Heterosexual dyad Woman-woman dyad Minimum Maximum
STING106
STING224
Fannyhessea vaginae 1 0 Yes 1 14 16
Gardnerella vaginalis Ac 1 0 Yes 1 38 51
Prevotella amnii 1 0 Yes 1 9 15
Sneathia sanguinegens 1 0 Yes 1 4 9
STING154
STING190
Gardnerella leopoldiic 1 0 Yes 0 58 88
STING168
STING201
Sneathia vaginalis 1 0 Yes 0 3 36
STING117
STING118
Lactobacillus iners 0 1 No 0.3 15 63
a

Strain concordance defined as ≥99.99% popANI over ≥50% of the length of the genomes. inStrain defines popANI based on popSNPs, which are called when two samples share no alleles at a given site.

b

CSTs assigned using VALENCIA.

c

For G. vaginalis A and G. leopoldii concordance events, relative abundances are presented for Gardnerella spp. at the genus level.

TABLE 3.

Interpersonal characteristics of strain-concordance events between non-contacts

Taxona N concordance eventsb Concordant between: Relative abundances in non-contact pairs with concordance Relative abundance ratio between non-contacts with concordance
Female participants Female and male participants Male participants Same CSTc Weeks between enrollment
N Row % N Row % N Row % N Row % Medd IQRd Minimum Maximum Medd Range
Fannyhessea spp. 1 0 0 1 100 0 0 1 100 63 4 5 1.1
Gardnerella leopoldii 7 4 57 3 43 0 0 5 71 54 24–96 13 88 1.7 1.1–6.7
Gardnerella piotii 1 1 100 0 0 0 0 1 100 4 56 75 1.3
Gardnerella spp. 1 1 100 0 0 0 0 0 0 149 29 30 1.0
Gardnerella swidsinskii 52 42 81 10 19 0 0 30 58 77 32–111 30 96 1.4 1.0–3.2
Gardnerella vaginalis 1 0 0 1 100 0 0 1 100 2 78 85 1.1
Lactobacillus crispatus 18 18 100 0 0 0 0 16 89 5 2–154 29 99 1.1 1.0–3.5
Lactobacillus iners 5 5 100 0 0 0 0 0 0 50 29–79 6 61 4.9 1.6–7.7
Lactobacillus jensenii 3 3 100 0 0 0 0 1 33 27 15–28 2 65 12.2 3.0–36.5
Lactobacillus mulieris 3 3 100 0 0 0 0 0 0 93 48–94 8 56 4.3 1.6–7.0
Limosilactobacillus portuensis 1 1 100 0 0 0 0 0 0 34 0.2 1 2.7
Megasphaera lornae 1 1 100 0 0 0 0 1 100 78 2 7 3.8
Mobiluncus curtisii 1 1 100 0 0 0 0 1 100 38 -- 2 3 1.7 --
Prevotella spp. 4 4 100 0 0 0 0 2 50 48 36–53
Prevotella amnii 3 3 100 0 0 0 0 1 33 66 34–67 2 7 2.1 1.6–3.4
Prevotella sp000758925 1 1 100 0 0 0 0 0 0 22
Prevotella timonensis 1 0 0 1 100 0 0 1 100 184 3 9 3.0
Staphylococcus epidermidis 1 1 100 0 0 0 0 1 100 197 2 7 4.4
Streptococcus agalactiae 1 1 100 0 0 0 0 0 0 190 19 97 5.1
Streptococcus anginosus 1 1 100 0 0 0 0 1 100 197 42 73 4.4
Streptococcus mitis 1 0 0 0 0 1 100 0 0 53 0.4 36 91.3
a

Relative abundance data are not presented for Prevotella spp. or Prevotella sp000758925 because there was no clear comparator taxon. Genus-level relative abundance data are presented for Fannyhessea spp., all Gardnerella spp., Megasphaera lornae, Mobiluncus curtisii, Staphylococcus epidermidis, and all Streptococcus spp. For Lactobacillus mulieris, relative abundance data from Lactobacillus jensenii are presented due to reclassification. For Limosilactobacillus portuensis, relative abundance data from Lactobacillus vaginalis are presented due to reclassification.

b

Strain concordance defined as ≥0.9999 popANI over ≥50% of the length of the genomes. inStrain defines popANI based on popSNPs, which are called when two samples share no alleles at a given site.

c

CSTs assigned using VALENCIA.

d

IQR, interquartile range; Med, median.

Fig 5.

Fig 5

Relatedness between concordant strains. Histogram of popANI between concordant strains, colored by taxon (A) Dot, box, and whisker plots of popSNP/Mbp between concordant strains, colored by taxon. (B) inStrain defines popANI based on popSNPs, which are called when two samples share no alleles at a given site.

Strain concordance between sexual contacts

Seven concordance events (6%) were between sexual contacts in four dyads. Strain concordance between contacts does not necessarily reflect sexual transmission within the dyad, so we applied additional criteria to determine which events likely represent recent sexual transmission. We considered strains that were concordant between contacts with <5 popSNP/Mbp to be sexually transmitted. Of seven concordance events between contacts, six met this criterion.

Heterosexual contacts (STING106 and STING224) enrolled 7 days apart had concordant F. vaginae (4.5 popSNP/Mbp), G. vaginalis A (30 popSNP/Mbp), P. amnii (1.3 popSNP/Mbp), and S. sanguinegens (0 popSNP/Mbp; Fig. 4, right middle). We consider these F. vaginae, P. amnii, and S. sanguinegens strains to be heterosexually transmitted. Both contacts were assigned to CST IV-B (Fig. 6). The female contact had CT and reported current contraceptive implant, current bloody vaginal discharge, and no BV history. The male contact was circumcised, screened negative for CT, and reported no symptoms (clinician noted scant urethral discharge). Both contacts reported being regular partners. Their most recent sex was 7–14 days previously, and they had sex three to five times in the prior 60 days with no condom use.

Fig 6.

Fig 6

Urogenital microbiota composition of sexual contacts with concordant strains. Each panel depicts urogenital microbiota composition for a unique sexual contact dyad with ≥1 concordant strains. The label at the top of each panel indicates the species of concordant strains that were identified as putatively sexually transmitted, and the x-axis labels indicate the sex of each contact.

Heterosexual contacts (STING154 and STING190) enrolled on the same day had concordant G. leopoldii (1.0 popSNP/Mbp; Fig. 4, bottom middle), which we consider heterosexually transmitted. Both contacts were assigned to CST IV-B and reported no symptoms. The female contact had CT and reported no BV history. The male contact was circumcised and screened negative for CT. Both contacts reported being occasional partners; their last sex was 1 month previously, and they had sex two to three times in the prior 60 days with no condom use.

Heterosexual contacts (STING168 and STING201) enrolled on the same day had concordant S. vaginalis (0 popSNP/Mbp; Fig. 4, bottom left), which we consider heterosexually transmitted. Both contacts were assigned to CST IV-B and had CT. The female contact reported current abnormal vaginal discharge (clinician reported no BV findings), current copper intrauterine device, and no BV history. The male contact was circumcised and reported no symptoms. These contacts reported discrepant characteristics of their sexual relationship. The female contact reported being regular partners; their last sex was 4 days previously, and they had sex four times in the prior 60 days with intermittent condom use. The male contact reported being new partners; their last sex was 0 days previously (within the prior 24 hours), and they had sex once with no condom use.

Female sexual contacts (STING117 and STING118) enrolled two days apart had concordant L. iners (0 popSNP/Mbp; Fig. 4, left middle), which we consider sexually transmitted. This was the only Lactobacillus strain concordant between contacts (no Lactobacillus concordance between heterosexual contacts). One contact each was assigned to CST III and CST IV-B. Both contacts had CT and reported no symptoms and no BV history; one contact reported current oral contraceptive use. They reported being regular partners; their last sex was 0 days prior to the first contact enrolling (within the prior 24 hours), and they had sex >20 times in the prior 60 days.

Strain concordance between non-contacts

Most concordance events (108, 94%) were between non-contacts, including 91 (84% of non-contact concordance) between female participants, 16 (15%) between female and male participants, and 1 (1%) between male participants.

Eight female participants were interconnected through 18 L. crispatus and 3 L. jensenii concordant strains (Fig. 4 top right). Seventeen of these concordance events were between participants assigned to CST I; four were between participants assigned to CST I and CST V (Fig. S2). Median popSNP/Mbp between non-contacts was 35 for L. crispatus and 2.9 for L. jensenii; each L. jensenii concordance event had <5 popSNP/Mbp. Participants concordant for L. crispatus were enrolled a median of 5 weeks apart; those concordant for L. jensenii were enrolled a median of 27 weeks apart.

Fourteen female and two male participants were densely interconnected through 52 G. swidsinskii concordance events (Fig. 4 left middle). Twenty-eight of these events were between participants assigned to CST IV-B, 22 between participants assigned to CST IV-A and CST IV-B, and 2 between participants assigned to CST IV-A (Fig. S3). All G. swidsinskii concordant strains showed >5 popSNP/Mbp (median = 59). Participants concordant for G. swidsinskii were enrolled a median of 77 weeks apart.

Comparing concordance between contacts and non-contacts

Because nearly half of participants did not have a contact enrolled and few concordance events were between contacts, we examined the prevalence of concordance/transmission among contacts and non-contacts. For non-contacts, we defined the prevalence denominator as the total number of unique participant pairs minus the number of contact dyads, which represents all possible opportunities for non-contact concordance. The aim here is to describe the relative frequency at which we observed concordance between contacts vs between non-contacts, not to generate precise population-level prevalence estimates.

With 138 participants, there are 9,453 unique 2-participant pairs. Forty-two were contact dyads, leaving 9,411 unique non-contact pairs. The prevalence of concordance/transmission was 9.5% between contacts (4 of 44 dyads had concordance/transmission) and 1.1% between non-contacts (104 of 9,411).

Considering putative heterosexual transmission, there were 74 female participants and 64 male, giving 4,736 unique female-male pairs. Thirty-nine were contact dyads, leaving 4,697 unique non-contact female-male pairs. The prevalence of concordance/transmission was 7.7% between female-male contact dyads (3 of 39) and 0.5% between non-contact female-male pairs (22 of 4,697).

Considering putative transmission between women, there were 2,701 unique female-female pairs. Two were contact dyads, leaving 2,699 unique non-contact female-female pairs. The prevalence of concordance/transmission was 50% between female-female contact dyads (1 of 2) and 3.2% between non-contact female-female pairs (87 of 2,699).

DISCUSSION

We present strain-level metagenomic evidence that strongly supports heterosexual transmission of BV-associated bacteria and sexual transmission of L. iners between female contacts. These findings are consistent with prior molecular biology studies of strain-level urogenital bacterial concordance (5056) and metataxonomic studies of species-level urogenital bacterial concordance (26, 28, 49, 57, 58) between sexual contacts. Importantly, genome-resolved metagenomics allowed us to address primary limitations of prior studies. Molecular biology studies characterized strain-level concordance but only for a prespecified genus or species (5056). Because BV is a polymicrobial condition whose etiology remains unclear (3, 35, 36, 39), targeted approaches cannot examine strain concordance for all potentially relevant taxa. Metataxonomic studies used 16S rRNA gene amplicon sequencing to characterize concordance throughout the vaginal and penile microbiotas but are limited to the species level or higher (26, 28, 49, 57, 58). Because species exist as multi-strain communities in the vagina (10, 59, 72), transmission cannot be inferred from species-level concordance. Genome-resolved metagenomics instead provided us an untargeted approach to identify concordant strains (>99.99% popANI, <5 popSNP/Mbp) in the vaginal and penile microbiomes of recent sexual contacts, providing strong support for sexual transmission of several BV-associated species and L. iners.

Whether BV can be sexually transmitted is debated (3538). This study cannot demonstrate heterosexual BV transmission; however, our observations do provide support for possible BV transmission. We identified putative heterosexual transmission of F. vaginae, G. leopoldii, P. amnii, S. sanguinegens, and S. vaginalis. Prior epidemiologic studies reported associations between these taxa and specific combinations of Amsel criteria; these associations were largely consistent between populations of Kenyan and American women (73, 74). In vitro and omics studies indicate these taxa may contribute to BV signs and symptoms via production of biogenic amines (7577) or extracellular enzymes that degrade cervicovaginal mucus (7880). Here, one of three female contacts with putative transmission of BV-associated taxa reported abnormal vaginal discharge (none reported odor). There were no clinical BV findings for these female contacts.

A primary argument against BV sexual transmission is that early male partner treatment trials showed little to no benefit for reducing BV recurrence (3946). These trials are subject to major limitations including insufficient randomization methods, lack of power calculations, suboptimal BV treatment regimens for women, and lack of adherence data (3946); that these trials did not demonstrate a reduction in BV recurrence among dyads randomized to male partner treatment should not be interpreted as evidence against heterosexual BV transmission. Recent years have seen a resurgence of interest in BV male partner treatment with multiple studies and trials completed and several under way (28, 4749). Identifying putative heterosexual transmission of BV-associated taxa strengthens the evidence base supporting these ongoing investigations. While we cannot comment on potential transmission of additional BV-associated bacteria, measuring the impact of male partner treatment on F. vaginae, G. leopoldii, P. amnii, S. sanguinegens, and S. vaginalis may provide insight into a regimen’s performance. Two recent pilot studies evaluated a combined regimen of oral metronidazole and topical clindamycin for male partners, which showed reductions in penile Prevotella spp. (28, 49). No other taxa we observed to be heterosexually transmitted were significantly reduced.

Another major area of ongoing research aims to rigorously design and test Lactobacillus live biotherapeutic products (LBPs) to achieve/maintain optimal vaginal microbiota composition and vaginal health. Our observation of putative L. iners transmission between female contacts suggests Lactobacillus LBP may be particularly beneficial for WSW as the strain(s) may be transmitted within dyads and WSW sexual networks. Given high BV concordance between female sex partners (31, 32), transmission of beneficial lactobacilli through WSW sexual networks could yield substantial gains in individual and community health. That said, Lactobacillus LBP research largely focuses on L. crispatus (81, 82), which shows substantial genomic, metabolic, and epidemiologic differences to L. iners (810, 83, 84). Without identifying putative transmission of other lactobacilli, it is unclear how generalizable the observation of L. iners transmission is to possible transmission of Lactobacillus LBP strains.

While our data do not provide evidence of L. crispatus sexual transmission, they also cannot rule it out. Importantly, only 2 of 43 contact dyads included two women, limiting our insight into sexual transmission of vaginal bacteria between women. The minimum relative abundance of any putatively transmitted strain was 3% (S. vaginalis). L. crispatus relative abundances among female non-contacts with L. crispatus concordance ranged from 29% to 99%, with five of eight ≥89%. Conversely, L. crispatus relative abundances ranged from 0.02% to 0.10% among contacts in WSW dyads, and the maximum L. crispatus relative abundance among male participants in contact dyads was 17%, with most <1% (Fig. S4). These values suggest that if any contact dyad had sexually transmitted L. crispatus, our analyses likely are not sensitive enough to detect this concordance.

Finally, we observed frequent strain concordance between non-contacts, primarily G. swidsinskii and L. crispatus between female participants. Because concordance/transmission was 9–16 times more prevalent among contact dyads compared to non-contact pairs, strain concordance between non-contacts should not be taken as evidence against putative sexual transmission. Frequent strain concordance between female non-contacts is consistent with a prior analysis of vaginal bacterial strain concordance within and between families in the Baltimore area. While some reproductive-age mothers and their reproductive-age daughters had concordant strains, participants were more likely to have a concordant strain with someone they were not related to than someone in their family (85). Substantial strain concordance between female non-contacts is also consistent with a recent person-level meta-analysis of 7,646 stool and 2,069 saliva metagenomes from 20 countries that showed non-negligible strain concordance in these microbiomes between non-cohabitating individuals in the same community (86).

We hypothesize that a high degree of strain concordance between unrelated and/or non-sexual-contact women may reflect limited dispersal capacity of vaginal bacteria coupled with individuals’ comembership in regional transmission networks (85). Here, we are considering regions the size of a metropolitan area because STING recruited participants from the Baltimore metropolitan area. However, our hypotheses may apply to any area that encompasses a sexual and/or urogenital bacteria transmission network. Because vaginal lactobacilli and Gardnerella spp. are rarely detected in the environment or human body sites other than the genitals and many vaginal bacteria are anaerobic, we posit that direct person-to-person transmission (e.g., between parent and child at birth, cohabitating individuals, or sexual contacts) may represent a primary means of geographic dispersal of vaginal bacteria (85). Under this assumption, we would expect sexual network characteristics to influence vaginal bacterial dispersal. In sexual networks, small groups of high-contact individuals, termed core groups, play an integral role in maintaining bacterial STI endemicity/outbreaks (87). This can largely be attributed to assortative mixing and partner concurrency: core group members disproportionately partner with other core group members and are more likely to have concurrent partners than non-core-group members (87), which sustains STI transmission within core groups. When core group members partner with non-core-group members, this disseminates the STI in the general population. Similar processes may drive maintenance and dispersal of network-specific consortia of urogenital bacterial strains. Network characteristics appear to influence pathogen phylogenies (88); evaluating whether this is true for all or specific members of the vaginal microbiome could vastly improve our understanding of vaginal microbial ecology and biogeography as well as BV etiology. The sexual networks enrolled in STING were small and isolated (Fig. S5), so we were not able to test these hypotheses.

This study should be interpreted in the context of its limitations. While these metagenomic data provide strong evidence supporting sexual transmission of urogenital bacteria, the study design is insufficient to prove sexual transmission or identify the direction of putative transmission. We cannot determine whether putatively transmitted strains engrafted in “recipient” contacts’ urogenital microbiomes. It is possible strains failed to engraft, but sufficient DNA was present at sampling to detect the transient concordant strain.

Second, penile urethral swabs yielded significantly fewer reads than vaginal swabs (median non-host reads: 2.3 × 105 for penile, 6.6 × 106 for vaginal, Kruskal-Wallis P = 2 × 10−16; Fig. S6). For a given MAG and pair of metagenomes, inStrain only compares sites on the MAG with ≥5× coverage in both metagenomes. Per-MAG number of comparable sites (≥5× coverage) was significantly greater in vaginal metagenomes than penile (Kruskal-Wallis P < 2 × 10−16). Vaginal and penile metagenomes had similar proportions of metagenome-MAG mappings with 0 comparable sites (~54%); however, among metagenome-MAG mappings with >0 comparable sites, the median per-MAG number of comparable sites was 535 for vaginal metagenomes (IQR 190–1,895) and 302 for penile metagenomes (IQR 168–780). Having significantly fewer comparable sites in penile metagenomes likely prevented concordance events involving male participants from meeting our criteria of ≥99.99% popANI over >50% shared coverage, and our analyses likely under-detected strain concordance/transmission between male and female participants.

Finally, STING participants were enrolled in the Baltimore area, had high CT prevalence, and were relatively young. It is unclear how generalizable these findings are to other geographic regions, less-densely populated settings, older populations, or populations with lower STI burden.

By integrating genome-resolved metagenomics in a sexual network study, we provide insight into the sexual transmissibility of the urogenital microbiota and vaginal bacterial biogeography. Our findings may have substantial implications for achieving and maintaining vaginal health among sexually active individuals, particularly via novel interventions including BV partner treatment and LBP. We believe these data represent only “the tip of the iceberg” when it comes to urogenital bacterial transmission: we likely under-detected transmission in heterosexual and WSW dyads, and we cannot comment on how representative our findings are. Additional studies in various geographic contexts and sexual networks with various characteristics are warranted to broaden our understanding of sexual transmission of the urogenital microbiota, vaginal bacterial biogeography, and whether these vary across populations.

MATERIALS AND METHODS

We used data and samples from the Sexually Transmitted Infection Network Groups study to evaluate urogenital bacterial strain concordance between sexual contacts and non-contacts. We report our results according to Strengthening the Organization and Reporting of Microbiome Studies guidelines (Table S2) (89).

STING recruitment and procedures

Between February 2016 and March 2020, participants were recruited from seven clinics providing CT/NG screening in the Baltimore, MD, USA, metropolitan area. Individuals were eligible if they screened positive for genital CT by NAAT, were 16–40 years old, and were willing to provide the names and contact information of all sexual contacts from the prior 60 or 180 days. Individuals were ineligible if they were living with HIV, ever exchanged sex for money or drugs, were taking immunosuppressive medications, had a severe medical condition, or were non-English-speaking (all self-report). Female individuals were ineligible if they were pregnant (point-of-care human chorionic gonadotropin urine test). Male individuals were ineligible if they exclusively had sex with men.

Wave 1 participants provided names and contact information of sexual contacts. Trained staff notified contacts of their STI exposure and invited them to enroll. Sexual contacts were eligible if they were 16–40 years old, willing to undergo CT/NG screening, and willing to provide names and contact information of their sexual contacts from the prior 60 or 180 days. Pregnant female contacts and male contacts who exclusively had sex with men were eligible for waves 2–4; otherwise, exclusions were the same as for wave 1. Snowball recruitment of sexual contacts continued for up to four waves. All participants and sexual contacts who screened positive for CT/NG were treated free of charge, after sample collection, based on national guidelines (90). We constructed a sexual network diagram (Fig. S5). Sexual networks were small and isolated from each other, so we did not examine sexual network characteristics.

Demographic information and medical history were collected via in-person interview, and the participants completed social and behavioral history questionnaires (online or paper). Vaginal or penile urethral swabs were collected during reproductive tract examination, immediately stored at −18°C, and transferred daily on ice to the Institute for Genome Sciences at the University of Maryland School of Medicine (UMSOM), where they were stored at −80°C.

Whole metagenome sequencing

Shotgun metagenomic data were generated for 138 samples (74 vaginal and 64 penile) as described previously (84). Swabs were resuspended in 1 mL of Amies transport medium. Genomic DNA was extracted using 200 µL of resuspended material and the MagAttract PowerMicrobiome DNA/RNA Kit (Qiagen) with bead-beating using TissueLyser II. Sequence libraries were generated from extracted DNA using the Illumina Nextera XT Flex kit. Procedures were performed according to manufacturer instructions and automated on the Hamilton STAR robotic platform. Libraries were sequenced on an Illumina NovaSeq 6000 (150 bp, paired-end) at Maryland Genomics at UMSOM. Host reads were identified and removed using BMtagger and the GRCh38 human genome as reference (91). Non-host reads were processed using fastp (v.0.21) (92). Metagenome taxonomic compositions were determined via mapping to VIRGO (59), and CSTs were assigned using VALENCIA (2). VALENCIA is a supervised classifier for the vaginal microbiome. The penile CST assignments we observed are consistent with prior unsupervised clustering results (25, 2729), so we feel it is reasonable to use VALENCIA with penile samples in STING.

Genome-resolved metagenomics

We de novo assembled each metagenome, individually, using metaSPAdes (60) with k-mer sizes of 21, 33, and 55. We divided assembled contigs into MAGs using MaxBin2 (v.2.2.7 -min_contig_length 500), MetaBAT2 (v.2.12.1, --maxEdges 500), and MetaDecoder (v.1.0.8, default settings) (6163). We consolidated and refined bins using MetaWRAP (v.1.3.2, bin_refinement, default settings), which estimates bin quality using CheckM (v.1.1.3, default settings) (64, 65). We retained MAGs determined to be ≥90% complete and <5% contaminated for analyses. MAG taxonomy was assigned using GTDB-Tk (v.2.1.1 classify work_wf, database release 207) (66).

Identification of strain concordance

We used inStrain to identify concordant strains between participants (68). We built inStrain profiles for each metagenome-MAG pair by mapping each metagenome’s reads against all retained MAGs using Bowtie2 (69). We summarized profiles using the inStrain compare function with Ward linkage, which reports coverage overlap and sequence similarity between each metagenome and each MAG. To measure sequence similarity, inStrain estimates popANI based on popSNPs, which are called when metagenomes share no alleles (major or minor) at a given site. To identify concordant strains, we applied stringent filters requiring ≥99.99% sequence similarity (popANI) over ≥50% shared coverage. We considered strains concordant between sexual contacts with <5 popSNP/Mbp to be sexually transmitted. Illumina NovaSeq 6000 error rates are ~0.1% (93); inStrain accounts for an error rate of 0.1%, so sequencing errors should not produce artifactual concordance/transmission events.

Several participant pairs appeared to be concordant for multiple strains of the same species. We assumed these participants were concordant for a single strain that mapped sufficiently well to multiple MAGs to meet concordance criteria when compared to multiple MAGs. For redundant events, we retained the event with the greatest number of base pairs compared and discarded remaining redundant events (215 events in 60 participant pairs discarded).

To identify and discard strain-concordance events likely resulting from contamination, we built inStrain profiles for the negative control sample. We used the same criteria as above to identify concordance between metagenomes and the negative control. We considered concordance to be due to contamination when two participants and the negative control were all concordant for the same strain, and we discarded four G. leopoldii concordance events likely resulting from contamination.

Statistical analysis

We performed two differential abundance analyses using the ZicoSeq and ZicoSeq.plot functions of the GUniFrac package (v.1.7) in R (v.4.2.1, throughout) (67). We compared vaginal and penile metagenome relative abundances, and we compared penile metagenome relative abundances by CT status. ZicoSeq uses a permutation-based approach for multiple comparisons adjustment, and we controlled FWER at 1% using 999 permutations.

We constructed a network diagram depicting strain concordance events using the network function of the network package (v.1.18.0, throughout) (94, 95), as_tbl_graph, and activate functions of the tidygraph package (v.1.2.2) (96) and ggraph function of the ggraph package (v.2.1.0) (97) in R. We summarized network size using the network.edgecount and network.size functions of the network package in R.

We used Kruskal-Wallis tests to evaluate whether popSNP/Mbp between concordant strains differed across species or when strains were concordant between contacts vs non-contacts, whether vaginal and penile non-host reads differed, and whether per-MAG comparable sites differed between vaginal and penile metagenomes. We considered hypothesis tests significant at P < 0.05 (two-tailed, no multiple comparisons adjustment).

ACKNOWLEDGMENTS

We thank all of the STING participants and study staff.

The research reported in this publication was supported in part by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number U19AI084044 (J.R.) and T32AI162579 (K.A.C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.

Author contributions are as follows: conceptualization—K.A.C., M.T.F., R.M.B., and J.R.; data curation—K.A.C., M.T.F., L.R., and M.R.; formal analysis—K.A.C. and M.T.F.; funding acquisition—K.A.C. and J.R.; clinical Investigation—L.B., S.M.-G., and M.R.; supervision—M.T.F., R.M.B., and J.R.; writing (original draft)—K.A.C.; writing (review and revisions)—K.A.C., M.T.F., L.R., M.R., R.M.B., and J.R.

Footnotes

Presented at: This work was presented at STI & HIV 2023 World Congress in Chicago, IL, USA, oral presentation OS1.4.

Contributor Information

Kayla A. Carter, Email: kaylacarter2@som.umaryland.edu.

Jacques Ravel, Email: jravel@som.umaryland.edu.

Maria L. Marco, University of California, Davis, Davis, California, USA

DATA AVAILABILITY

Whole metagenome sequencing data are in the Short Read Archive (PRJNA798061). All scripts used to process and analyze metagenomes are available at GitHub. Additional data are available in the supplemental material.

ETHICS APPROVAL

STING is approved by the University of Maryland, Baltimore Institutional Review Board (HP-00060235, approved through 24 January 2024). All participants provided written informed consent prior to eligibility screening and a second written informed consent prior to study procedures if they chose to enroll.

SUPPLEMENTAL MATERIAL

The following material is available online at https://doi.org/10.1128/msphere.00030-24.

Figure S1. msphere.00030-24-s0001.tiff.

Differential abundance of taxa between penile metagenomes from male participants with CT/NG vs. without CT/NG.

DOI: 10.1128/msphere.00030-24.SuF1
Figure S2. msphere.00030-24-s0002.tiff.

Urogenital microbiota composition of female non-contacts with Lactobacillus crispatus and/or Lactobacillus jensenii concordance.

DOI: 10.1128/msphere.00030-24.SuF2
Figure S3. msphere.00030-24-s0003.tiff.

Urogenital microbiota composition of non-contacts with Gardnerella swidsinskii concordance.

DOI: 10.1128/msphere.00030-24.SuF3
Figure S4. msphere.00030-24-s0004.tiff.

Distribution of Lactobacillus crispatus relative abundances among female contacts in WSW dyads and male contacts in contact dyads.

DOI: 10.1128/msphere.00030-24.SuF4
Figure S5. msphere.00030-24-s0005.tiff.

STING sexual network diagram.

DOI: 10.1128/msphere.00030-24.SuF5
Figure S6. msphere.00030-24-s0006.tiff.

Penile urethral swabs yielded significantly fewer non-host reads than vaginal swabs.

DOI: 10.1128/msphere.00030-24.SuF6
Supplemental material legends. msphere.00030-24-s0007.docx.

Supplemental figure and table legends.

DOI: 10.1128/msphere.00030-24.SuF7
Table S1. msphere.00030-24-s0008.xlsx.

MAG inventory.

DOI: 10.1128/msphere.00030-24.SuF8
Table S2. msphere.00030-24-s0009.xlsx.

STORMS checklist.

DOI: 10.1128/msphere.00030-24.SuF9

ASM does not own the copyrights to Supplemental Material that may be linked to, or accessed through, an article. The authors have granted ASM a non-exclusive, world-wide license to publish the Supplemental Material files. Please contact the corresponding author directly for reuse.

REFERENCES

  • 1. Kaul R, Liu CM, Park DE, Galiwango RM, Tobian AAR, Prodger JL. 2022. The penis, the vagina and HIV risk: key differences (aside from the obvious). Viruses 14:1164. doi: 10.3390/v14061164 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. France MT, Ma B, Gajer P, Brown S, Humphrys MS, Holm JB, Waetjen LE, Brotman RM, Ravel J. 2020. VALENCIA: a nearest centroid classification method for vaginal microbial communities based on composition. Microbiome 8:166. doi: 10.1186/s40168-020-00934-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Muzny CA, Kardas P. 2020. A narrative review of current challenges in the diagnosis and management of bacterial vaginosis. Sex Transm Dis 47:441–446. doi: 10.1097/OLQ.0000000000001178 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Mehta SD, Zulaika G, Otieno FO, Nyothach E, Agingu W, Bhaumik R, Green SJ, van Eijk AM, Kwaro D, Phillips-Howard PA. 2021. High prevalence of Lactobacillus crispatus dominated vaginal microbiome among Kenyan secondary school girls: negative effects of poor quality menstrual hygiene management and sexual activity. Front Cell Infect Microbiol 11:716537. doi: 10.3389/fcimb.2021.716537 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Nunn KL, Wang Y-Y, Harit D, Humphrys MS, Ma B, Cone R, Ravel J, Lai SK. 2015. Enhanced trapping of HIV-1 by human cervicovaginal mucus is associated with Lactobacillus crispatus-dominant microbiota. mBio 6:e01084-15. doi: 10.1128/mBio.01084-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Edwards VL, Smith SB, McComb EJ, Tamarelle J, Ma B, Humphrys MS, Gajer P, Gwilliam K, Schaefer AM, Lai SK, Terplan M, Mark KS, Brotman RM, Forney LJ, Bavoil PM, Ravel J. 2019. The cervicovaginal microbiota-host interaction modulates Chlamydia trachomatis infection. mBio 10:e01548-19. doi: 10.1128/mBio.01548-19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Petrova MI, Reid G, Vaneechoutte M, Lebeer S. 2017. Lactobacillus iners: friend or foe? Trends Microbiol 25:182–191. doi: 10.1016/j.tim.2016.11.007 [DOI] [PubMed] [Google Scholar]
  • 8. Carter KA, Fischer MD, Petrova MI, Balkus JE. 2023. Epidemiologic evidence on the role of Lactobacillus iners in sexually transmitted infections and bacterial vaginosis: a series of systematic reviews and meta-analyses. Sex Transm Dis 50:224–235. doi: 10.1097/OLQ.0000000000001744 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Holm JB, Carter KA, Ravel J, Brotman RM. 2023. Lactobacillus iners and genital health: molecular clues to an enigmatic vaginal species. Curr Infect Dis Rep 25:67–75. doi: 10.1007/s11908-023-00798-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. France MT, Mendes-Soares H, Forney LJ, Schloss PD. 2016. Genomic comparisons of Lactobacillus crispatus and Lactobacillus iners reveal potential ecological drivers of community composition in the vagina. Appl Environ Microbiol 82:7063–7073. doi: 10.1128/AEM.02385-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Gosmann C, Anahtar MN, Handley SA, Farcasanu M, Abu-Ali G, Bowman BA, Padavattan N, Desai C, Droit L, Moodley A, Dong M, Chen Y, Ismail N, Ndung’u T, Ghebremichael MS, Wesemann DR, Mitchell C, Dong KL, Huttenhower C, Walker BD, Virgin HW, Kwon DS. 2017. Lactobacillus-deficient cervicovaginal bacterial communities are associated with increased HIV acquisition in young South African women. Immunity 46:29–37. doi: 10.1016/j.immuni.2016.12.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Munoz A, Hayward MR, Bloom SM, Rocafort M, Ngcapu S, Mafunda NA, Xu J, Xulu N, Dong M, Dong KL, Ismail N, Ndung’u T, Ghebremichael MS, Kwon DS. 2021. Modeling the temporal dynamics of cervicovaginal microbiota identifies targets that may promote reproductive health. Microbiome 9:163. doi: 10.1186/s40168-021-01096-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Holm JB, France MT, Ma B, McComb E, Robinson CK, Mehta A, Tallon LJ, Brotman RM, Ravel J. 2020. Comparative metagenome-assembled genome analysis of “Candidatus Lachnocurva vaginae”, formerly known as bacterial vaginosis-associated bacterium−1 (BVAB1). Front Cell Infect Microbiol 10:117. doi: 10.3389/fcimb.2020.00117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Nouioui I, Carro L, García-López M, Meier-Kolthoff JP, Woyke T, Kyrpides NC, Pukall R, Klenk H-P, Goodfellow M, Göker M. 2018. Genome-based taxonomic classification of the phylum Actinobacteria. Front Microbiol 9:2007. doi: 10.3389/fmicb.2018.02007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Peebles K, Velloza J, Balkus JE, McClelland RS, Barnabas RV. 2019. High global burden and costs of bacterial vaginosis: a systematic review and meta-analysis. Sex Transm Dis 46:304–311. doi: 10.1097/OLQ.0000000000000972 [DOI] [PubMed] [Google Scholar]
  • 16. Nugent RP, Krohn MA, Hillier SL. 1991. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 29:297–301. doi: 10.1128/jcm.29.2.297-301.1991 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. 1983. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations. Am J Med 74:14–22. doi: 10.1016/0002-9343(83)91112-9 [DOI] [PubMed] [Google Scholar]
  • 18. Chow K, Wooten D, Annepally S, Burke L, Edi R, Morris SR. 2023. Impact of (recurrent) bacterial vaginosis on quality of life and the need for accessible alternative treatments. BMC Womens Health 23:112. doi: 10.1186/s12905-023-02236-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Atashili J, Poole C, Ndumbe PM, Adimora AA, Smith JS. 2008. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS 22:1493–1501. doi: 10.1097/QAD.0b013e3283021a37 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Peelen MJ, Luef BM, Lamont RF, de Milliano I, Jensen JS, Limpens J, Hajenius PJ, Jørgensen JS, Menon R, PREBIC Biomarker Working Group 2014–2018 . 2019. The influence of the vaginal microbiota on preterm birth: a systematic review and recommendations for a minimum dataset for future research. Placenta 79:30–39. doi: 10.1016/j.placenta.2019.03.011 [DOI] [PubMed] [Google Scholar]
  • 21. Tamarelle J, Thiébaut ACM, de Barbeyrac B, Bébéar C, Ravel J, Delarocque-Astagneau E. 2019. The vaginal microbiota and its association with human papillomavirus, Chlamydia trachomatis, Neisseria gonorrhea and Mycoplasma genitalium infections: a systematic review and meta-analysis. Clin Microbiol Infect 25:35–47. doi: 10.1016/j.cmi.2018.04.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Bowden SJ, Doulgeraki T, Bouras E, Markozannes G, Athanasiou A, Grout-Smith H, Kechagias KS, Ellis LB, Zuber V, Chadeau-Hyam M, Flanagan JM, Tsilidis KK, Kalliala I, Kyrgiou M. 2023. Risk factors for human papillomavirus infection, cervical intraepithelial neoplasia and cervical cancer: an umbrella review and follow-up Mendelian randomisation studies. BMC Med 21:274. doi: 10.1186/s12916-023-02965-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Bradshaw CS, Morton AN, Hocking J, Garland SM, Morris MB, Moss LM, Horvath LB, Kuzevska I, Fairley CK. 2006. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 193:1478–1486. doi: 10.1086/503780 [DOI] [PubMed] [Google Scholar]
  • 24. Prodger JL, Abraham AG, Tobian AAR, Park DE, Aziz M, Roach K, Gray RH, Buchanan L, Kigozi G, Galiwango RM, Ssekasanvu J, Nnamutete J, Kagaayi J, Kaul R, Liu CM. 2021. Penile bacteria associated with HIV seroconversion, inflammation, and immune cells. JCI Insight 6:e147363. doi: 10.1172/jci.insight.147363 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Toh E, Xing Y, Gao X, Jordan SJ, Batteiger TA, Batteiger BE, Van Der Pol B, Muzny CA, Gebregziabher N, Williams JA, Fortenberry LJ, Fortenberry JD, Dong Q, Nelson DE. 2023. Sexual behavior shapes male genitourinary microbiome composition. Cell Rep Med 4:100981. doi: 10.1016/j.xcrm.2023.100981 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Zozaya M, Ferris MJ, Siren JD, Lillis R, Myers L, Nsuami MJ, Eren AM, Brown J, Taylor CM, Martin DH. 2016. Bacterial communities in penile skin, male urethra, and vaginas of heterosexual couples with and without bacterial vaginosis. Microbiome 4:16. doi: 10.1186/s40168-016-0161-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Mehta SD, Zhao D, Green SJ, Agingu W, Otieno F, Bhaumik R, Bhaumik D, Bailey RC. 2020. The microbiome composition of a man’s penis predicts incident bacterial vaginosis in his female sex partner with high accuracy. Front Cell Infect Microbiol 10:433. doi: 10.3389/fcimb.2020.00433 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Plummer EL, Vodstrcil LA, Doyle M, Danielewski JA, Murray GL, Fehler G, Fairley CK, Bulach DM, Garland SM, Chow EPF, Hocking JS, Bradshaw CS, Onderdonk AB. 2021. A prospective, open-label pilot study of concurrent male partner treatment for bacterial vaginosis. mBio 12:e0232321. doi: 10.1128/mBio.02323-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Mehta SD, Nandi D, Agingu W, Green SJ, Otieno FO, Bhaumik DK, Bailey RC. 2022. Longitudinal changes in the composition of the penile microbiome are associated with circumcision status, HIV and HSV-2 status, sexual practices, and female partner microbiome composition. Front Cell Infect Microbiol 12:916437. doi: 10.3389/fcimb.2022.916437 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Jespers V, Kyongo J, Joseph S, Hardy L, Cools P, Crucitti T, Mwaura M, Ndayisaba G, Delany-Moretlwe S, Buyze J, Vanham G, van de Wijgert J. 2017. A longitudinal analysis of the vaginal microbiota and vaginal immune mediators in women from sub-Saharan Africa. Sci Rep 7:11974. doi: 10.1038/s41598-017-12198-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Marrazzo JM, Koutsky LA, Eschenbach DA, Agnew K, Stine K, Hillier SL. 2002. Characterization of vaginal flora and bacterial vaginosis in women who have sex with women. J Infect Dis 185:1307–1313. doi: 10.1086/339884 [DOI] [PubMed] [Google Scholar]
  • 32. Vodstrcil LA, Walker SM, Hocking JS, Law M, Forcey DS, Fehler G, Bilardi JE, Chen MY, Fethers KA, Fairley CK, Bradshaw CS. 2015. Incident bacterial vaginosis (BV) in women who have sex with women is associated with behaviors that suggest sexual transmission of BV. Clin Infect Dis 60:1042–1053. doi: 10.1093/cid/ciu1130 [DOI] [PubMed] [Google Scholar]
  • 33. Ratten LK, Plummer EL, Murray GL, Danielewski J, Fairley CK, Garland SM, Hocking JS, Tachedjian G, Chow E, Bradshaw CS, Vodstrcil LA. 2021. Sex is associated with the persistence of non-optimal vaginal microbiota following treatment for bacterial vaginosis: a prospective cohort study. BJOG 128:756–767. doi: 10.1111/1471-0528.16430 [DOI] [PubMed] [Google Scholar]
  • 34. Vodstrcil LA, Plummer ME, Fairley CK, Tachedjian G, Law MG, Hocking JS, Worthington MK, Grant MM, Okoko N, Bradshaw CS. 2019. Combined oral contraceptive pill-exposure alone does not reduce the risk of bacterial vaginosis recurrence in a pilot randomised controlled trial. Sci Rep 9:3555. doi: 10.1038/s41598-019-39879-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, Reno H, Zenilman JM, Bolan GA. 2021. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep 70:1–187. doi: 10.15585/mmwr.rr7004a1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Muzny CA, Balkus J, Mitchell C, Sobel JD, Workowski K, Marrazzo J, Schwebke JR. 2022. Diagnosis and management of bacterial vaginosis: summary of evidence reviewed for the 2021 centers for disease control and prevention sexually transmitted infections treatment guidelines. Clin Infect Dis 74:S144–S151. doi: 10.1093/cid/ciac021 [DOI] [PubMed] [Google Scholar]
  • 37. Kenyon CR, Delva W, Brotman RM. 2019. Differential sexual network connectivity offers a parsimonious explanation for population-level variations in the prevalence of bacterial vaginosis: a data-driven, model-supported hypothesis. BMC Womens Health 19:8. doi: 10.1186/s12905-018-0703-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Muzny CA, Taylor CM, Swords WE, Tamhane A, Chattopadhyay D, Cerca N, Schwebke JR. 2019. An updated conceptual model on the pathogenesis of bacterial vaginosis. J Infect Dis 220:1399–1405. doi: 10.1093/infdis/jiz342 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Vodstrcil LA, Muzny CA, Plummer EL, Sobel JD, Bradshaw CS. 2021. Bacterial vaginosis: drivers of recurrence and challenges and opportunities in partner treatment. BMC Med 19:194. doi: 10.1186/s12916-021-02077-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Mehta SD. 2012. Systematic review of randomized trials of treatment of male sexual partners for improved bacteria vaginosis outcomes in women. Sex Transm Dis 39:822–830. doi: 10.1097/OLQ.0b013e3182631d89 [DOI] [PubMed] [Google Scholar]
  • 41. Swedberg J, Steiner JF, Deiss F, Steiner S, Driggers DA. 1985. Comparison of single-dose vs one-week course of metronidazole for symptomatic bacterial vaginosis. JAMA 254:1046–1049. [PubMed] [Google Scholar]
  • 42. Vejtorp M, Bollerup AC, Vejtorp L, Fanøe E, Nathan E, Reiter A, Andersen ME, Strømsholt B, Schrøder SS. 1988. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. BJOG 95:920–926. doi: 10.1111/j.1471-0528.1988.tb06581.x [DOI] [PubMed] [Google Scholar]
  • 43. Mengel MB, Berg AO, Weaver CH, Herman DJ, Herman SJ, Hughes VL, Koepsell TD. 1989. The effectiveness of single-dose metronidazole therapy for patients and their partners with bacterial vaginosis. J Fam Pract 28:163–171. [PubMed] [Google Scholar]
  • 44. Moi H, Erkkola R, Jerve F, Nelleman G, Bymose B, Alaksen K, Tornqvist E. 1989. Should male consorts of women with bacterial vaginosis be treated? Genitourin Med 65:263–268. doi: 10.1136/sti.65.4.263 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Vutyavanich T, Pongsuthirak P, Vannareumol P, Ruangsri R-A, Luangsook P. 1993. A randomized double-blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstet Gynecol 82:550–554. [PubMed] [Google Scholar]
  • 46. Colli E, Landoni M, Parazzini F. 1997. Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourin Med 73:267–270. doi: 10.1136/sti.73.4.267 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Vodstrcil LA, Plummer EL, Doyle M, Fairley CK, McGuiness C, Bateson D, Hocking JS, Law MG, Petoumenos K, Donovan B, Chow EPF, Bradshaw CS, Kaldor J, McNulty A, Lewis DA, Chen MY, Bilardi JE, Tabrizi SN, Murray GL, Danielewski J, Garland SM, McNamee K. 2020. Treating male partners of women with bacterial vaginosis (StepUp): a protocol for a randomised controlled trial to assess the clinical effectiveness of male partner treatment for reducing the risk of BV recurrence. BMC Infect Dis 20:834. doi: 10.1186/s12879-020-05563-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Schwebke JR, Lensing SY, Lee J, Muzny CA, Pontius A, Woznicki N, Aguin T, Sobel JD. 2021. Treatment of male sexual partners of women with bacterial vaginosis: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis 73:e672–e679. doi: 10.1093/cid/ciaa1903 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Plummer EL, Vodstrcil LA, Danielewski JA, Murray GL, Fairley CK, Garland SM, Hocking JS, Tabrizi SN, Bradshaw CS. 2018. Combined oral and topical antimicrobial therapy for male partners of women with bacterial vaginosis: acceptability, tolerability and impact on the genital microbiota of couples-a pilot study. PLoS One 13:e0190199. doi: 10.1371/journal.pone.0190199 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Plummer EL, Vodstrcil LA, Murray GL, Fairley CK, Danielewski JA, Garland SM, Chow EPF, Bulach DM, Fethers KA, Hocking JS, Bradshaw CS. 2020. Gardnerella vaginalis clade distribution is associated with behavioral practices and nugent score in women who have sex with women. J Infect Dis 221:454–463. doi: 10.1093/infdis/jiz474 [DOI] [PubMed] [Google Scholar]
  • 51. Eren AM, Zozaya M, Taylor CM, Dowd SE, Martin DH, Ferris MJ. 2011. Exploring the diversity of Gardnerella vaginalis in the genitourinary tract microbiota of monogamous couples through subtle nucleotide variation. PLoS One 6:e26732. doi: 10.1371/journal.pone.0026732 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Weindling AM, Hawkins JM, Coombes MA, Stringer J. 1981. Colonisation of babies and their families by group B streptococci. Br Med J (Clin Res Ed) 283:1503–1505. doi: 10.1136/bmj.283.6305.1503 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Marrazzo JM, Antonio M, Agnew K, Hillier SL. 2009. Distribution of genital Lactobacillus strains shared by female sex partners. J Infect Dis 199:680–683. doi: 10.1086/596632 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Ma L, Taylor S, Jensen JS, Myers L, Lillis R, Martin DH. 2008. Short tandem repeat sequences in the Mycoplasma genitalium genome and their use in a multilocus genotyping system. BMC Microbiol 8:130. doi: 10.1186/1471-2180-8-130 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Bilek N, Martin IM, Bell G, Kinghorn GR, Ison CA, Spratt BG. 2007. Concordance between Neisseria gonorrhoeae genotypes recovered from known sexual contacts. J Clin Microbiol 45:3564–3567. doi: 10.1128/JCM.01453-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Schillinger JA, Katz BP, Markowitz LE, Braslins PG, Shrier LA, Madico G, Van Der Pol B, Orr DP, Rice PA, Batteiger BE. 2016. Genotype-specific concordance of Chlamydia trachomatis genital infection within heterosexual partnerships. Sex Transm Dis 43:741–749. doi: 10.1097/OLQ.0000000000000525 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57. Mändar R, Punab M, Borovkova N, Lapp E, Kiiker R, Korrovits P, Metspalu A, Krjutškov K, Nõlvak H, Preem J-K, Oopkaup K, Salumets A, Truu J. 2015. Complementary seminovaginal microbiome in couples. Res Microbiol 166:440–447. doi: 10.1016/j.resmic.2015.03.009 [DOI] [PubMed] [Google Scholar]
  • 58. Mehta SD, Nandi D, Agingu W, Green SJ, Bhaumik DK, Bailey RC, Otieno F. 2022. Vaginal and penile microbiome associations with herpes simplex virus type 2 in women and their male sex partners. J Infect Dis 226:644–654. doi: 10.1093/infdis/jiaa529 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Ma B, France MT, Crabtree J, Holm JB, Humphrys MS, Brotman RM, Ravel J. 2020. A comprehensive non-redundant gene catalog reveals extensive within-community intraspecies diversity in the human vagina. Nat Commun 11:940. doi: 10.1038/s41467-020-14677-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Nurk S, Meleshko D, Korobeynikov A, Pevzner PA. 2017. metaSPAdes: a new versatile metagenomic assembler. Genome Res 27:824–834. doi: 10.1101/gr.213959.116 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61. Wu Y-W, Simmons BA, Singer SW. 2016. MaxBin 2.0: an automated binning algorithm to recover genomes from multiple metagenomic datasets. Bioinformatics 32:605–607. doi: 10.1093/bioinformatics/btv638 [DOI] [PubMed] [Google Scholar]
  • 62. Kang DD, Li F, Kirton E, Thomas A, Egan R, An H, Wang Z. 2019. MetaBAT 2: an adaptive binning algorithm for robust and efficient genome reconstruction from metagenome assemblies. PeerJ 7:e7359. doi: 10.7717/peerj.7359 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63. Liu C-C, Dong S-S, Chen J-B, Wang C, Ning P, Guo Y, Yang T-L. 2022. MetaDecoder: a novel method for clustering metagenomic contigs. Microbiome 10:46. doi: 10.1186/s40168-022-01237-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64. Uritskiy GV, DiRuggiero J, Taylor J. 2018. MetaWRAP-a flexible pipeline for genome-resolved metagenomic data analysis. Microbiome 6:158. doi: 10.1186/s40168-018-0541-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65. Parks DH, Imelfort M, Skennerton CT, Hugenholtz P, Tyson GW. 2015. CheckM: assessing the quality of microbial genomes recovered from isolates, single cells, and metagenomes. Genome Res 25:1043–1055. doi: 10.1101/gr.186072.114 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66. Chaumeil P-A, Mussig AJ, Hugenholtz P, Parks DH, Hancock J. 2019. GTDB-Tk: a toolkit to classify genomes with the genome taxonomy database. Bioinformatics 36:1925–1927. doi: 10.1093/bioinformatics/btz848 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67. Yang L, Chen J. 2022. A comprehensive evaluation of microbial differential abundance analysis methods: current status and potential solutions. Microbiome 10:130. doi: 10.1186/s40168-022-01320-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68. Olm MR, Crits-Christoph A, Bouma-Gregson K, Firek BA, Morowitz MJ, Banfield JF. 2021. inStrain profiles population microdiversity from metagenomic data and sensitively detects shared microbial strains. Nat Biotechnol 39:727–736. doi: 10.1038/s41587-020-00797-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69. Langmead B, Salzberg SL. 2012. Fast gapped-read alignment with Bowtie 2. Nat Methods 9:357–359. doi: 10.1038/nmeth.1923 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70. Rocha J, Botelho J, Ksiezarek M, Perovic SU, Machado M, Carriço JA, Pimentel LL, Salsinha S, Rodríguez-Alcalá LM, Pintado M, Ribeiro TG, Peixe L. 2020. Lactobacillus mulieris sp. nov., a new species of Lactobacillus delbrueckii group. Int J Syst Evol Microbiol 70:1522–1527. doi: 10.1099/ijsem.0.003901 [DOI] [PubMed] [Google Scholar]
  • 71. Eisenberg T, Gronow S, Falgenhauer J, Imirzalioglu C, Mühldorfer K, Rau J, Blom J, Fawzy A, Glaeser SP, Kämpfer P. 2019. Sneathia vaginalis sp. nov. (Fusobacteriales, Leptotrichiaceae) as a replacement of the species “Sneathia amnii” Harwich et al. 2012 and “Leptotrichia amnionii” Shukla et al. 2002, and emended description of Sneathia Collins et al. 2001. Int J Syst Evol Microbiol 71. doi: 10.1099/ijsem.0.004663 [DOI] [PubMed] [Google Scholar]
  • 72. Vaneechoutte M, Guschin A, Van Simaey L, Gansemans Y, Van Nieuwerburgh F, Cools P. 2019. Emended description of Gardnerella vaginalis and description of Gardnerella leopoldii sp. nov., Gardnerella piotii sp. nov. and Gardnerella swidsinskii sp. nov., with delineation of 13 genomic species within the genus Gardnerella. Int J Syst Evol Microbiol 69:679–687. doi: 10.1099/ijsem.0.003200 [DOI] [PubMed] [Google Scholar]
  • 73. Carter KA, Balkus JE, Anzala O, Kimani J, Hoffman NG, Fiedler TL, Mochache V, Fredricks DN, McClelland RS, Srinivasan S. 2022. Associations between vaginal bacteria and bacterial vaginosis signs and symptoms: a comparative study of Kenyan and American women. Front Cell Infect Microbiol 12:801770. doi: 10.3389/fcimb.2022.801770 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74. Srinivasan S, Hoffman NG, Morgan MT, Matsen FA, Fiedler TL, Hall RW, Ross FJ, McCoy CO, Bumgarner R, Marrazzo JM, Fredricks DN, Ratner AJ. 2012. Bacterial communities in women with bacterial vaginosis: high resolution phylogenetic analyses reveal relationships of microbiota to clinical criteria. PLoS One 7:e37818. doi: 10.1371/journal.pone.0037818 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75. Nelson TM, Borgogna J-LC, Brotman RM, Ravel J, Walk ST, Yeoman CJ. 2015. Vaginal biogenic amines: biomarkers of bacterial vaginosis or precursors to vaginal dysbiosis? Front Physiol 6:253. doi: 10.3389/fphys.2015.00253 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76. Srinivasan S, Morgan MT, Fiedler TL, Djukovic D, Hoffman NG, Raftery D, Marrazzo JM, Fredricks DN. 2015. Metabolic signatures of bacterial vaginosis. mBio 6:e00204-15. doi: 10.1128/mBio.00204-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77. Yeoman CJ, Thomas SM, Miller MEB, Ulanov AV, Torralba M, Lucas S, Gillis M, Cregger M, Gomez A, Ho M, Leigh SR, Stumpf R, Creedon DJ, Smith MA, Weisbaum JS, Nelson KE, Wilson BA, White BA, Ratner AJ. 2013. A multi-omic systems-based approach reveals metabolic markers of bacterial vaginosis and insight into the disease. PLoS One 8:e56111. doi: 10.1371/journal.pone.0056111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78. Yeoman CJ, Yildirim S, Thomas SM, Durkin AS, Torralba M, Sutton G, Buhay CJ, Ding Y, Dugan-Rocha SP, Muzny DM, Qin X, Gibbs RA, Leigh SR, Stumpf R, White BA, Highlander SK, Nelson KE, Wilson BA, Li W. 2010. Comparative genomics of Gardnerella vaginalis strains reveals substantial differences in metabolic and virulence potential. PLoS One 5:e12411. doi: 10.1371/journal.pone.0012411 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79. Marconi C, Donders GG, Parada C, Giraldo PC, da Silva MG. 2013. Do Atopobium vaginae, Megasphaera sp. and Leptotrichia sp. change the local innate immune response and sialidase activity in bacterial vaginosis? Sex Transm Infect 89:167–173. doi: 10.1136/sextrans-2012-050616 [DOI] [PubMed] [Google Scholar]
  • 80. Olmsted SS, Meyn LA, Rohan LC, Hillier SL. 2003. Glycosidase and proteinase activity of anaerobic gram-negative bacteria isolated from women with bacterial vaginosis. Sex Transm Dis 30:257–261. doi: 10.1097/00007435-200303000-00016 [DOI] [PubMed] [Google Scholar]
  • 81. Cohen CR, Wierzbicki MR, French AL, Morris S, Newmann S, Reno H, Green L, Miller S, Powell J, Parks T, Hemmerling A. 2020. Randomized trial of Lactin-V to prevent recurrence of bacterial vaginosis. N Engl J Med 382:1906–1915. doi: 10.1056/NEJMoa1915254 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82. Mahmoud MY, Wesley M, Kyser A, Lewis WG, Lewis AL, Steinbach-Rankins JM, Frieboes HB. 2023. Lactobacillus crispatus-loaded electrospun fibers yield viable and metabolically active bacteria that kill Gardnerella in vitro. Eur J Pharm Biopharm 187:68–75. doi: 10.1016/j.ejpb.2023.04.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83. Bloom SM, Mafunda NA, Woolston BM, Hayward MR, Frempong JF, Abai AB, Xu J, Mitchell AJ, Westergaard X, Hussain FA, Xulu N, Dong M, Dong KL, Gumbi T, Ceasar FX, Rice JK, Choksi N, Ismail N, Ndung’u T, Ghebremichael MS, Relman DA, Balskus EP, Mitchell CM, Kwon DS. 2022. Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation. Nat Microbiol 7:434–450. doi: 10.1038/s41564-022-01070-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84. France MT, Fu L, Rutt L, Yang H, Humphrys MS, Narina S, Gajer PM, Ma B, Forney LJ, Ravel J. 2022. Insight into the ecology of vaginal bacteria through integrative analyses of metagenomic and metatranscriptomic data. Genome Biol 23:66. doi: 10.1186/s13059-022-02635-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85. France MT, Brown SE, Rompalo AM, Brotman RM, Ravel J. 2022. Identification of shared bacterial strains in the vaginal microbiota of related and unrelated reproductive-age mothers and daughters using genome-resolved metagenomics. PLOS One 17:e0275908. doi: 10.1371/journal.pone.0275908 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86. Valles-Colomer M, Blanco-Míguez A, Manghi P, Asnicar F, Dubois L, Golzato D, Armanini F, Cumbo F, Huang KD, Manara S, et al. 2023. The person-to-person transmission landscape of the gut and oral microbiomes. Nature 614:125–135. doi: 10.1038/s41586-022-05620-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87. Gesink DC, Sullivan AB, Miller WC, Bernstein KT. 2011. Sexually transmitted disease core theory: roles of person, place, and time. Am J Epidemiol 174:81–89. doi: 10.1093/aje/kwr035 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88. Robinson K, Fyson N, Cohen T, Fraser C, Colijn C. 2013. How the dynamics and structure of sexual contact networks shape pathogen phylogenies. PLoS Comput Biol 9:e1003105. doi: 10.1371/journal.pcbi.1003105 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89. Mirzayi C, Renson A, Zohra F, Elsafoury S, Geistlinger L, Kasselman LJ, Eckenrode K, van de Wijgert J, Loughman A, Marques FZ, et al. 2021. Reporting guidelines for human microbiome research: the STORMS checklist. Nat Med 27:1885–1892. doi: 10.1038/s41591-021-01552-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90. Workowski KA, Bolan GA, Centers for Disease Control and Prevention . 2015. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 64:1–137. [PMC free article] [PubMed] [Google Scholar]
  • 91. Rotmistrovsky K, Agarwala R. 2011. BMTagger: best match tagger for removing human reads from metagenomic data- sets. NCBI/NLM, NIH; 2011
  • 92. Chen S, Zhou Y, Chen Y, Gu J. 2018. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34:i884–i890. doi: 10.1093/bioinformatics/bty560 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93. Stoler N, Nekrutenko A. 2021. Sequencing error profiles of Illumina sequencing instruments. NAR Genom Bioinform 3:lqab019. doi: 10.1093/nargab/lqab019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94. Butts CT. 2008. network: a package for managing relational data in R. J Stat Softw 24:1–36. doi: 10.18637/jss.v024.i0218612375 [DOI] [Google Scholar]
  • 95. Butts CT. 2015. network: classes for relational data (1.18.0). R. The Statnet Project. [Google Scholar]
  • 96. Pedersen TL. 2023. tidygraph: a tidy API for graph manipulation (1.2.2). R
  • 97. Pedersen TL. 2022. ggraph: an implementation of grammar of graphics for graphs and networks (2.1.0). R

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Figure S1. msphere.00030-24-s0001.tiff.

Differential abundance of taxa between penile metagenomes from male participants with CT/NG vs. without CT/NG.

DOI: 10.1128/msphere.00030-24.SuF1
Figure S2. msphere.00030-24-s0002.tiff.

Urogenital microbiota composition of female non-contacts with Lactobacillus crispatus and/or Lactobacillus jensenii concordance.

DOI: 10.1128/msphere.00030-24.SuF2
Figure S3. msphere.00030-24-s0003.tiff.

Urogenital microbiota composition of non-contacts with Gardnerella swidsinskii concordance.

DOI: 10.1128/msphere.00030-24.SuF3
Figure S4. msphere.00030-24-s0004.tiff.

Distribution of Lactobacillus crispatus relative abundances among female contacts in WSW dyads and male contacts in contact dyads.

DOI: 10.1128/msphere.00030-24.SuF4
Figure S5. msphere.00030-24-s0005.tiff.

STING sexual network diagram.

DOI: 10.1128/msphere.00030-24.SuF5
Figure S6. msphere.00030-24-s0006.tiff.

Penile urethral swabs yielded significantly fewer non-host reads than vaginal swabs.

DOI: 10.1128/msphere.00030-24.SuF6
Supplemental material legends. msphere.00030-24-s0007.docx.

Supplemental figure and table legends.

DOI: 10.1128/msphere.00030-24.SuF7
Table S1. msphere.00030-24-s0008.xlsx.

MAG inventory.

DOI: 10.1128/msphere.00030-24.SuF8
Table S2. msphere.00030-24-s0009.xlsx.

STORMS checklist.

DOI: 10.1128/msphere.00030-24.SuF9

Data Availability Statement

Whole metagenome sequencing data are in the Short Read Archive (PRJNA798061). All scripts used to process and analyze metagenomes are available at GitHub. Additional data are available in the supplemental material.


Articles from mSphere are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES